Cytoplasmic legumain is often associated with neurodegenerative phenotypes, where it cleaves tau (58), α-synuclein (108), and SET (109) to promote neurofibrillary tangles, plaque formation, and cognitive impairment. Here, MAPT is linked to Cognitive impairment.